ASHLEY BROYLES: Open Payments
NPI 1790202828 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 29 payments from 8 companies in 2025. Trend: 2023 $502 · 2024 $529 · 2025 $460
Food & beverage: $441Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $193 |
| PFIZER INC. | 5 | $93 |
| Novo Nordisk Inc | 2 | $50 |
| Boston Scientific Corporation | 1 | $37 |
| Amgen Inc. | 2 | $28 |
| Seqirus USA Inc | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: UBRELVY, QULIPTA, PREVNAR 20, VRAYLAR, WATCHMAN FLX, NURTEC ODT, Flucelvax, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
